Synthesis, physicochemical and anticonvulsant properties of new N-(pyridine-2-yl) derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3- dione. Part II

Archiv der Pharmazie

Volumn 339, Issue 5, 2006, Pages 255-261

  Kaminski, Krzysztof ^a   Obniska, Jolanta ^a   Zagorska, Agnieszka ^a   Maclag, Dorota ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

2 Azaspiro 4.4 nonane 1,3 dione; 2 Azaspiro 4.5 decane 1,3 dione; Anticonvulsant activity; Calcium channel receptors affinity; Lipophilicity

Indexed keywords

ANTICONVULSIVE AGENT; N (3 METHYLPYRIDINE 2 YL) 2 AZASPIRO[4.4]NONANE 1,3 DIONE; N (3 METHYLPYRIDINE 2 YL) 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (3 METHYLPYRIDINE 2 YL) 6 METHYL 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (4 METHYLPYRIDINE 2 YL) 2 AZASPIRO[4.4]NONANE 1,3 DIONE; N (4 METHYLPYRIDINE 2 YL) 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (4 METHYLPYRIDINE 2 YL) 6 METHYL 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (4,6 DIMETHYLPYRIDINE 2 YL) 2 AZASPIRO[4.4]NONANE 1,3 DIONE; N (4,6 DIMETHYLPYRIDINE 2 YL) 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (4,6 DIMETHYLPYRIDINE 2 YL) 6 METHYL 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (6 METHYLPYRIDINE 2 YL) 2 AZASPIRO[4.4]NONANE 1,3 DIONE; N (6 METHYLPYRIDINE 2 YL) 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (6 METHYLPYRIDINE 2 YL) 6 METHYL 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N (PYRIDINE 2 YL) 6 METHYL 2 AZASPIRO[4.5]DECANE 1,3 DIONE; N PYRIDINE 2 YL 2 AZASPIRO[4.4]NONANE 1,3 DIONE; N PYRIDINE 2 YL 2 AZASPIRO[4.5]DECANE 1,3 DIONE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; LIPOPHILICITY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY;

ANIMALS; ANTICONVULSANTS; MICE; PYRIDINES; RATS; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33744480575     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200500219     Document Type: Article

References (29)

1. M. J. Brodie, Epilepsy Res. 2001, 45, 3-6.
2. E. Estrada, A. Pena, Bioorg. Med. Chem. 2000, 8, 2755-2770.
3. J. Obniska, K. Kulig, A. Zejc, Acta Polon. Pharm.-Drug Res. 1998, 55, 223-231.
4. J. Obniska, A. Zejc, A. Zagorska, Acta Polon. Pharm.-Drug Res. 2002, 59, 209-213.
5. J. Obniska, A. Zagorska, Il Framaco 2003, 58, 1227-1234.
6. J. Obniska, A. Zejc, J. Karolak-Wojciechowska, Il Farmaco 1999, 54, 423-429.
7. A. Zejc, J. Obniska, E. Chojnacka-Wojcik, E. Tatarczynska, B. Wiczynska, Pol. J. Pharmacol. Pharm. 1987, 39, 91-95.
8. A. Zejc, J. Obniska, M. Wilimowski, M. Rutkowska, M. Witkowska, J. Barczynska, L. Kedzierska-Gozdzik, W. Wojewódzki, K. Orzechowska- Juzwenko, T. Plawiak, E. Dus, J. Gryska, H. Gliniak, Pol. J. Pharmacol. Pharm. 1990, 42, 69-77.
9. J. Karolak-Wojciechowska, W. Kwiatkowski, J. Obniska, A. Zejc, Acta Crystallogr. 1990, C46, 108-112.
10. J. Karolak-Wojciechowska, W. Kwiatkowski, J. Obniska, A. Zejc, Acta Crystallogr. 1996, C52, 1808-1809.
11. M. L. Traver, J. M. Nicholson, K. R. Scott, J. Pharm. Sci. 1985, 74, 785-787.
12. M. S. Alexander, J. P. Stables, M. Ciechanowicz-Rutkowska, M. B. Hursthouse, D. E. Hibbs, I. O. Edafiogho, V. A. Moore, K. R. Scott, Eur. J. Med. Chem. 1996, 31, 787-795.
13. J. Obniska, A. Dzierzawska-Majewska, A. Zagorska, P. Zajdel, J. Karolak-Wojciechowska, Il Farmaco 2005, 60, 529-539.
14. P. C. Jones, Eur. J. Pharm. 2002, 447, 211-225.
15. K. R. Scott, J. A. Moore, T. B. Zalusky, J. M. Nicholson, M. Lee, J. Med. Chem. 1985, 28, 413-417.
16. F. A. El-Talbany, K. M. Ghoneim, M. Khalifa, Pharmazie 1976, 31, 442-444.
17. F. A. El-Talbany, K. M. Ghoneim, M. Khalifa, J. Pharm. Be;g. 1976, 403-410.
18. J. R. Huguenard, Epilepsy Curr. 2002, 2, 49-52.
19. J. Walden, H. Grunze, D. Bingmann, Z. Liu, R. Dusing, Eur. Neuropsychopharmacol. 1992, 2, 455-462.
20. C. Sarbu, D. Casoni, M. Darabantu, C. Maiereanu, J. Pharm. Biomed. Anal. 2004, 35, 213-219.
21. F. Hollosy, T. Lorand, L. Orfi, D. Eros, G. Keri, M. Idei, J. Chromatogr. B 2002, 768, 361-368.
22. F. Hollosy, J. Seprodi, L. Orfi, D. Eros, G. Keri, M. Idei, J. Chromatogr. B 2002, 780, 355-363.
23. N. U. Perisic-Janjic, M. M. Acanski, N. J. Janjic, M. D. Lazarevic, V. Dimova, J. Planar Chromatogr. 2000, 13, 281-284.
24. J. Obniska, K. Kaminski, J. Planar Chromatogr. 2005, 18, 240-243.
25. R. L. Krall, J. K. Penry, B. G. White, H. J. Kupferberg, E. A. Swinyard, Epilepsia 1978, 19, 409-428.
26. H. J. Kupferberg, Epilepsia 1989, 30, 51-56.
27. L. Antkiewicz-Michaluk, J. Michaluk, R. Romanska, J. Vetulani, Eur. J. Pharmacol. 1990, 180, 129-135.
28. O. H. Lowry, N. J. Rosebrough, A. L. Farr, R. J. Randall, J. Biol. Chem. 1951, 191, 265-275.
29. K. Dross, C. Sonntag, R. Mannhold, J. Chromatogr. A 1994, 673, 113-124.